HALT-3 study : Automatic summary report

Study number of the facility : [ltcf_id_1] Date of the survey : [ltcf_id_2]
Number of eligible residents : [ltcf_id_3] Number of completed resident forms : [ltcf_id_4]
INFECTIONS
Total number of confirmed infections: [infections_1]
Total number of imported infections: [infections_19]
Total number of probable urinary tract infections: [infections_18]
Total number of 'other' infections: [infections_20]
Total number of infections with the current LTCF as origin of infection: [Reporting_Q6]
Number
Urinary tract [infections_2]
Respiratory tract [infections_4]
Skin/Wound [infections_6]
Gastro-intestinal [infections_8]
Eye, ear, mouth,.. [infections_10]
Systemic infection [infections_12]
Unexplained fever [infections_14]
Other [infections_16]
ANTIMICROBIAL (AM) USE
Total number of residents with antimicrobial(s): [antibiotics_20]
Total number of molecules: [antibiotics_1]
Total number (%) of antimicrobials by class :
Number % of total
Tetracyclines (J01A) [antibiotics_2] [antibiotics_3]
Amphenicols (J01B) [antibiotics_4] [antibiotics_5]
Beta-lactams (J01C) [antibiotics_6] [antibiotics_7]
Cephalosporins and other beta-lactams (J01D) [antibiotics_8] [antibiotics_9]
Sulfonamides, Trimethoprim (J01E) [antibiotics_10] [antibiotics_11]
Macrolides, lincosamides, streptogramins (J01F) [antibiotics_12] [antibiotics_13]
Aminoglycosides (J01G) [antibiotics_14] [antibiotics_15]
Quinolones (J01M) [antibiotics_16] [antibiotics_17]
Other antimicrobials (J01X) [antibiotics_18] [antibiotics_19]
MICROBIOLOGICAL RESULTS Number
Number of microorganisms reported [microorganisms_3]
RESISTANT MICRO-ORGANISMS Number of isolates
Clostridium difficile [microorganisms_30]
Staphylococcus aureus (MRSA, Oxacillin-R) [microorganisms_4]
Staphylococcus aureus (GLY-R) [microorganisms_5]
Acinetobacter baumannii (Carba-R) [microorganisms_7]
Enterococcus species (Glyco-R) [microorganisms_9]
Enterobacter species (3rd gen. Cephalo-R) [microorganisms_11]
Enterobacter species (Carba-R) [microorganisms_23]
Escherichia coli (3rd gen. Cephalo-R) [microorganisms_13]
Escherichia coli (Carba-R) [microorganisms_25]
Klebsiella species (3rd gen. Cephalo-R) [microorganisms_15]
Klebsiella species (Carba-R) [microorganisms_27]
Proteus species (3rd gen. Cephalo-R) [microorganisms_17]
Proteus species (Carba-R) [microorganisms_29]
Pseudomonas aeruginosa (Carba-R) [microorganisms_19]

HALT-3 study : Automatic summary report (page 2)

RESIDENT CHARACTERISTICS
  Total number residents % total resident population Resident with infection(s) Resident with antimicrobial(s)
> 85 years [residents_characteristics_31] [residents_characteristics_1] [residents_characteristics_2] [residents_characteristics_3]
Male residents [residents_characteristics_32] [residents_characteristics_4] [residents_characteristics_5] [residents_characteristics_6]
Urinary catheter [residents_characteristics_33] [residents_characteristics_7] [residents_characteristics_8] [residents_characteristics_9]
Vascular catheter [residents_characteristics_34] [residents_characteristics_10] [residents_characteristics_11] [residents_characteristics_12]
Pressure sore [residents_characteristics_35] [residents_characteristics_13] [residents_characteristics_14] [residents_characteristics_15]
Other wounds [residents_characteristics_36] [residents_characteristics_16] [residents_characteristics_17] [residents_characteristics_18]
Disorientation [residents_characteristics_37] [residents_characteristics_19] [residents_characteristics_20] [residents_characteristics_21]
Wheelchair/bedridden [residents_characteristics_38] [residents_characteristics_22] [residents_characteristics_23] [residents_characteristics_24]
Surgery (30 last days) [residents_characteristics_39] [residents_characteristics_25] [residents_characteristics_26] [residents_characteristics_27]
Incontinence [residents_characteristics_40] [residents_characteristics_28] [residents_characteristics_29] [residents_characteristics_30]
INFECTION CONTROL AND ANTIMICROBIAL STEWARDSHIP RESOURCES
I – Clinical governance [infectionctrl_1] /6 points
II – Infection control indicators [infectionctrl_2] /7 points
III - Hand hygiene indicators [infectionctrl_3] /5 points
IV- Protocols for infection control [infectionctrl_4] /6 points
V – Antimicrobial stewardship indicators [infectionctrl_5] /11 points
VI- Infection diagnosis/laboratory support [infectionctrl_6] /4 points
VII – Surveillance [infectionctrl_7] /3 points